Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 49651-49700 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05335148
Study to Evaluate the Safety of Colchicine
PHASE1Recruiting
30 participants
Started: May 10, 2022 · Completed: Jun 1, 2024
1 condition1 sponsor3 locations
NCT06433830
Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy
PHASE2Recruiting
50 participants
Started: May 10, 2022 · Completed: Jul 30, 2025
2 conditions1 sponsor1 location
NCT05274425
A 24-week rPMS Study in Real-world Setting for Enerzair
N/ARecruiting
600 participants
Started: May 9, 2022 · Completed: Mar 11, 2027
1 condition1 sponsor16 locations
NCT05712668
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors
NARecruiting
100 participants
Started: May 9, 2022 · Completed: May 31, 2025
2 conditions2 sponsors1 location
NCT05206487
Hepatic Encephalopathy Prevention With Polydextrose After TIPS: Pilot Study (POEME)
NARecruiting
30 participants
Started: May 9, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT06363903
ASIA-Mesh: a Pilot Study for Diagnostics and Treatment on ASIA Syndrome Caused by Polypropylene Mesh Implantation
N/ARecruiting
50 participants
Started: May 9, 2022 · Completed: May 31, 2025
6 conditions3 sponsors3 locations
NCT04400539
The IMmunotherapy Pleural 5-ALA PDT
PHASE2Recruiting
20 participants
Started: May 9, 2022 · Completed: May 9, 2026
2 conditions2 sponsors1 location
NCT05442151
Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
NARecruiting
200 participants
Started: May 9, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05260606
Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer
N/ARecruiting
100 participants
Started: May 9, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05393388
Tau Pet Imaging in the Aging Brain Cohort Dedicated to Diversity Study
N/ARecruiting
160 participants
Started: May 9, 2022 · Completed: May 31, 2027
2 conditions2 sponsors1 location
NCT05130996
Observational Study Evaluating Safety and Performance of IDI Dental Implant Systems in Subjects Followed for 18 Months.
N/ARecruiting
121 participants
Started: May 9, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05234463
Study of the Link Between Complement Activation and IgA Nephropathy Severity
N/ARecruiting
400 participants
Started: May 9, 2022 · Completed: May 1, 2027
1 condition1 sponsor1 location
NCT05179954
Lipoprotein Kinetics in T1D
NARecruiting
30 participants
Started: May 9, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05217810
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
N/ARecruiting
600 participants
Started: May 9, 2022 · Completed: Dec 23, 2026
1 condition1 sponsor18 locations
NCT05333627
Internet-delivered Cognitive Behaviour Therapy for Students: Duration Preference Trial
NARecruiting
200 participants
Started: May 9, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05072236
Effects of Adding Different Drugs for Preventing Cough Induced by Bronchoscopic Spraying of Local Anesthetics
NARecruiting
90 participants
Started: May 9, 2022 · Completed: Oct 30, 2024
3 conditions1 sponsor1 location
NCT05342441
Optimizing Graft Selection for ACL Reconstruction
NARecruiting
150 participants
Started: May 9, 2022 · Completed: May 31, 2028
1 condition3 sponsors1 location
NCT04832009
Reversing Glucose and Lipid-mediated Vascular Dysfunction
EARLY_PHASE1Recruiting
46 participants
Started: May 9, 2022 · Completed: Aug 1, 2027
2 conditions1 sponsor1 location
NCT05427435
Feasibility of Ethanolization of Vein of Marshall With Specific Catheter in Atrial Fibrillation Ablation
NARecruiting
40 participants
Started: May 9, 2022 · Completed: May 30, 2027
1 condition1 sponsor1 location
NCT04650607
Phage Safety Cohort Study
N/ARecruiting
100 participants
Started: May 9, 2022 · Completed: May 9, 2028
2 conditions1 sponsor1 location
NCT05327543
Effects of Online Yoga on the Quality of Life of Breast Cancer Patients
NARecruiting
138 participants
Started: May 9, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05134012
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
PHASE3Recruiting
215 participants
Started: May 8, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor13 locations
NCT05350891
Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
PHASE2Recruiting
77 participants
Started: May 8, 2022 · Completed: May 8, 2026
1 condition2 sponsors8 locations
NCT05068349
For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
PHASE4Recruiting
300 participants
Started: May 7, 2022 · Completed: Dec 31, 2025
7 conditions1 sponsor1 location
NCT05374252
Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients
PHASE3Recruiting
102 participants
Started: May 7, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06458114
Feeling of Caregivers After a Palliative Management of Extreme Premature Babies in Delivery Room.
N/ARecruiting
50 participants
Started: May 7, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT05505487
Construction and Effect Evaluation of Integrated Care Model for Pulmonary Infection in Stroke Patients With Tracheotomy
NARecruiting
80 participants
Started: May 7, 2022 · Completed: May 7, 2026
2 conditions1 sponsor1 location
NCT05294731
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
PHASE1/PHASE2Recruiting
146 participants
Started: May 6, 2022 · Completed: Sep 30, 2027
9 conditions1 sponsor29 locations
NCT06063278
Step by Step Group Therapy for Bulimia Nervosa: Effectiveness and Mechanisms of Change.
NARecruiting
100 participants
Started: May 6, 2022 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT06516406
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
N/ARecruiting
1,055 participants
Started: May 6, 2022 · Completed: May 31, 2032
3 conditions1 sponsor26 locations
NCT05801471
Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression
N/ARecruiting
200 participants
Started: May 6, 2022 · Completed: Nov 6, 2025
1 condition1 sponsor2 locations
NCT05405374
OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study
NARecruiting
101 participants
Started: May 6, 2022 · Completed: Oct 31, 2025
5 conditions1 sponsor9 locations
NCT04976881
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
NARecruiting
840 participants
Started: May 6, 2022 · Completed: May 31, 2026
4 conditions3 sponsors1 location
NCT05759637
Type 2 Diabetes, Obesity and Cortisol Excess
N/ARecruiting
3,200 participants
Started: May 6, 2022 · Completed: Dec 6, 2025
3 conditions5 sponsors5 locations
NCT06404840
Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
PHASE2Recruiting
30 participants
Started: May 6, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05392088
Characterization and Prognostic Role of Myocardial Injury in Patients With COVID-19. The CardioCOVID Gemelli Study.
N/ARecruiting
1,500 participants
Started: May 6, 2022 · Completed: Aug 31, 2024
2 conditions1 sponsor1 location
NCT05287867
Trial for Treating Painful Degenerative Disc Disease
NARecruiting
42 participants
Started: May 6, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT05141513
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma
PHASE1Recruiting
25 participants
Started: May 6, 2022 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT05334277
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA
PHASE2Recruiting
280 participants
Started: May 6, 2022 · Completed: Feb 29, 2028
1 condition3 sponsors26 locations
NCT05303415
Study of Low-intensity Focused Ultrasound Effects on Heat Evoked fMRI Signals
NARecruiting
80 participants
Started: May 6, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04848064
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
PHASE1Recruiting
12 participants
Started: May 6, 2022 · Completed: Jan 30, 2026
4 conditions1 sponsor1 location
NCT05761470
Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation
PHASE2Recruiting
66 participants
Started: May 6, 2022 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT06195462
Effects of Laying on of Hands in Fibromyalgia
NARecruiting
72 participants
Started: May 6, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05264818
Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma
N/ARecruiting
100 participants
Started: May 6, 2022 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT05310643
Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC
PHASE2Recruiting
30 participants
Started: May 5, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor9 locations
NCT00775476
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
PHASE2Recruiting
290 participants
Started: May 5, 2022 · Completed: Sep 30, 2028
1 condition9 sponsors8 locations
NCT06263920
Neurofrailty: A Study of Late-onset Epilepsy and Its Associations
N/ARecruiting
360 participants
Started: May 5, 2022 · Completed: Jan 12, 2027
3 conditions1 sponsor1 location
NCT05180825
Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy
PHASE2Recruiting
134 participants
Started: May 5, 2022 · Completed: Dec 1, 2031
3 conditions1 sponsor25 locations
NCT04960579
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
PHASE1Recruiting
231 participants
Started: May 5, 2022 · Completed: Dec 31, 2039
1 condition2 sponsors21 locations
NCT05301114
Social Risk Factors and Discrimination in Cancer Survivorship
NARecruiting
1,116 participants
Started: May 5, 2022 · Completed: Sep 30, 2026
5 conditions4 sponsors1 location